Single-dose, patient-initiated famciclovir: A randomized, double-blind, placebo-controlled trial for episodic treatment of herpes labialis
- 1 July 2006
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 55 (1) , 47-53
- https://doi.org/10.1016/j.jaad.2006.02.031
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- High-Dose, Short-Duration, Early Valacyclovir Therapy for Episodic Treatment of Cold Sores: Results of Two Randomized, Placebo-Controlled, Multicenter StudiesAntimicrobial Agents and Chemotherapy, 2003
- Age‐Specific Prevalence of Infection with Herpes Simplex Virus Types 2 and 1: A Global ReviewThe Journal of Infectious Diseases, 2002
- Effective treatment of herpes simplex labialis with penciclovir creamThe Journal of the American Dental Association, 2002
- Penciclovir Cream for the Treatment of Herpes Simplex LabialisPublished by American Medical Association (AMA) ,1997
- The Clinical Pharmacokinetics of FamciclovirClinical Pharmacokinetics, 1996
- Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virusAntimicrobial Agents and Chemotherapy, 1992
- Treatment of Recurrent Herpes Simplex Labialis with Oral AcyclovirThe Journal of Infectious Diseases, 1990
- Oral acyclovir and herpes labialis: a randomized, double-blind, placebo-controlled studyThe Journal of the American Dental Association, 1987
- Pathogenesis of recurrent herpes simplex labialis. IV. Maturation of lesions within 8 hours after onset and implications for antiviral treatmentOral Surgery, Oral Medicine, Oral Pathology, 1984
- The Natural History of Recurrent Herpes Simplex LabialisNew England Journal of Medicine, 1977